- Postincarceration Fatal Overdoses
Postincarceration Fatal Overdoses
Bottom Line: There were fewer postincarceration deaths from overdose among recently released inmates after a program was started to provide medications for addiction treatment (including methadone, buprenorphine or naltrexone) in a state correctional system.
Why The Research Is Interesting: Most correctional facilities in the United States don’t initiate or continue to provide medications for addiction treatment to inmates. Rates of opioid overdose are higher immediately after inmates are released from incarceration. A program for screening and treatment with medications for addiction treatment was launched in the Rhode Island Department of Corrections (RIDOC) in 2016. Inmates entering RIDOC who were receiving medications for addiction treatment maintained their medication regimens and community centers helped to link inmates with medication and supportive care after they were released. This research letter is a preliminary examination of that program.
Who and When: All unintentional deaths from overdose in Rhode Island from January to June in 2016 and 2017; individuals who died within 12 months of release from RIDOC
What (Study Measures): Compared the proportion of people who died from accidental overdose who were incarcerated in 2017 with those incarcerated in 2016 since individual-level data of enrollment in the medications for addiction treatment program were unavailable.
How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and therefore cannot control all the natural differences that could explain the study findings.
Authors: Traci C. Green, Ph.D., M.Sc., of the Warren Alpert Medical School of Brown University, Providence, Rhode Island, and coauthors
Results: 26 of 179 individuals (14.5 percent) who died of an overdose in the first six months of 2016 were recently incarcerated compared with 9 of 157 (5.7 percent) in the same period in 2017, a 60.5 percent reduction in mortality.
Study Limitations: A small study sample and a lack of data on medications for addiction treatment after an inmate’s release were some of the limitations of the study that warrant additional analyses.
Study Conclusions: Identifying and treating opioid use disorder in criminal justice settings, along with linking inmates to medication and supportive care after they are released, is a promising strategy to address high rates of overdose and opioid use disorder.
For more details and to read the full study, please visit the For The Media website.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.